Dose escalation for secondary loss of response in inflammatory bowel disease: 3-year outcomes and treatment persistence
{{output}}
Background: Dose escalation of biologic therapies is commonly used to manage secondary loss of response in inflammatory bowel disease, although long-term real-world outcomes remain limited. ... ...
